0858 Share Price

Open 0.26 Change Price %
High 0.26 1 Day -0.01 -3.70
Low 0.26 1 Week -0.02 -7.14
Close 0.26 1 Month 0.00 0.00
Volume 1640000 1 Year -0.12 -31.58
52 Week High 0.39
52 Week Low 0.24
0858 Important Levels
Resistance 2 0.26
Resistance 1 0.26
Pivot 0.26
Support 1 0.26
Support 2 0.26
HKG HongKong Most Active Stocks
0136 0.57 -17.39%
0261 0.01 0.00%
0566 3.91 0.00%
8173 0.01 -66.67%
0939 5.79 -0.17%
2324 0.06 -14.29%
3988 3.52 -0.56%
1398 4.77 0.42%
0981 1.00 0.00%
0061 0.02 0.00%
More..
HKG HongKong Top Gainers Stocks
0412 0.59 31.11%
8037 0.32 28.00%
0915 3.06 22.40%
0395 0.14 16.67%
8220 0.17 13.33%
8200 0.10 11.11%
8057 2.15 10.26%
0281 0.54 10.20%
3828 1.31 10.08%
8116 0.22 10.00%
More..
HKG HongKong Top Losers Stocks
8173 0.01 -66.67%
8231 0.25 -28.57%
4333 60.00 -25.00%
0136 0.57 -17.39%
8002 4.00 -15.97%
2324 0.06 -14.29%
1555 0.79 -14.13%
8081 0.09 -10.00%
8286 0.54 -10.00%
8201 0.09 -10.00%
More..

Extrawell Pharma. (HKG: 0858)

0858 Technical Analysis 4
As on 5th Dec 2016 0858 Share Price closed @ 0.26 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 0.28 & Sell for SHORT-TERM with Stoploss of 0.27 we also expect STOCK to react on Following IMPORTANT LEVELS.
0858 Target for December
1st Target up-side 0.32
2nd Target up-side 0.36
3rd Target up-side 0.4
1st Target down-side 0.22
2nd Target down-side 0.18
3rd Target down-side 0.14
0858 Other Details
Segment EQ
Market Capital 0.00
Sector Healthcare
Industry Drug Manufacturers - Major
Offical website http://www.extrawell.com.hk
0858 Address
0858
Devon House
Suites 2206-08
Quarry Bay,
Hong Kong
Phone: 852 2856 1918
Fax: 852 2856 3139
Interactive Technical Analysis Chart Extrawell Pharma. ( 0858 HKG HongKong )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on Extrawell Pharma.
0858 Business Profile
Extrawell Pharmaceutical Holdings Limited, an investment holding company, engages in the development, manufacture, and sale of pharmaceutical products in the People’s Republic of China. The company operates through Manufacturing, Trading, Gene development, and Oral Insulin segments. It offers Transfer Factor Oral Solution, a dual immune regulator for the treatment of diseases caused by virus infection and weak cellular immune system; and Wisk for the treatment of II-III degree of radio-injury of skin, normal common burn, actinic dermatitis, various infectious ulcers, and oral ulcers, as well as for trauma and post operation wound healing. The company also provides ZhouBang, a thromboxane synthetase inhibitor to prevent the coagulation of platelets and facilitate relaxation of blood vessels; Feining Pian, which is used for the treatment of chronic cough, acute upper respiratory tract infection, infection associated with bronchitis, and emphysema; and YouHuanPing, a sustained-release tablet for sideropenic anemia. It is also involved in the marketing and distribution of imported pharmaceutical products consisting of GM-1 to treat lesions of central nervous system due to vascular or traumatic events and Parkinson's disease; Millibar for the treatment of high blood pressure; and Skin-Cap for use in the treatment of psoriasis, dandruff, dermatitis, atopic dermatitis, eczema, and tinea. In addition, the company engages in the commercial exploitation and development of genome-related technology; development and commercialization of oral insulin products; and provision of agency services. Further, it engages in property investment business. Extrawell Pharmaceutical Holdings Limited is headquartered in Quarry Bay, Hong Kong.